Hot Products
| Catalog No. | Information |
| CFN95416 | Erythro-Guaiacylglycerol-beta-coniferyl aldehyde ether Erythro-Guaiacylglycerol-beta-coniferyl aldehyde ether,cytotoxic effects on human cancer cell lines |
| CFN91670 | Erythrosin B Erythrosine B is an artificial dye widely used in the food and textile industries. Erythrosine B is also a novel photosensitizer which has been used to develop animal models.Erythrosin B, a potent inhibitor for flaviviruses.Erythrosin B can act as a central excitatory agent able to induce hyperkinetic behavior. |
| CFN95363 | Eschweilenol C Eschweilenol C has antifungal, anti-inflammatory, antioxidant, antidiabetic activity. 4-(alpha-rhamnopyranosyl)ellagic acid is an inhibitor of human recombinant aldose reductase HRAR (IC50 = 4.1 x 10(-8) M). |
| CFN93368 | Escin IA Escin IA is a prodrug and its structure can be converted to desacylescin I by human intestinal bacteria and Lactobacillus brevis., desacylescin I as a biotransformation product shows potentially inhibitory effects on mouse tumor, and a potential candidate for anti tumor agents. Escin IA has anti-TNBC metastasis activity, and its action mechanisms involved inhibition of EMT process by down-regulating LOXL2 expression. |
| CFN90934 | Escin IB Escin Ib inhibits gastric emptying, at least in part, mediated by capsaicin-sensitive sensory nerves, to stimulate the synthesis and/or release of dopamine, to act through central dopamine2 receptor, which in turn causes the release of PGs. |
| CFN99059 | Esculentic acid Esculentic acid has anti-inflammatory effect, it has protective effects against LPS-induced endotoxic shock may be mediated, at least in part, by regulation the release of inflammatory cytokines and mediators, and protein expression of COX-2 in mice. |
| CFN98162 | Esculentoside A Esculentoside A has anti-inflammatory activity , can suppress inflammatory responses in LPS-induced ALI through inhibition of the nuclear factor kappa B and mitogen activated protein kinase signaling pathways. Esculentoside A may be useful for the treatment of autoimmune disease through modulation on T cell-mediated adaptive immunity. Esculentoside A treatment can attenuate CCl4 and GalN/LPS-induced acute liver injury in mice. |
| CFN98163 | Esculentoside B Phytolaccoside B(Esculentoside B) is an antifungal monodesmoside triterpenoid glycoside, it has potent inhibitory activity against agrobacterial plant transformation. |
| CFN98164 | Esculentoside C Esculentoside C exerts proinflammatory effects synergistically, it can induce inflammatory stimulation. |
| CFN90657 | Esculentoside H Phytolaccaceae has anti-tumor activity, the mechanism may be related to the capacity of Esculentoside H for TNF release. |
